The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Arthritis & Rheumatism

Topics

Medicine

Pathology

Internal Medicine

Surgery

Gastroenterology

Show all topics

DOI

10.1002/art.21778